Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Blindness, low vision, and other handicaps as risk factors attached to institutional residence

    BREZIN A,LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G

    Br J Ophtalmol ; 88(10):1330-1337

  • Économie de la santĂ©

    Clinical outcomes of glaucoma Treatments Over a patient lifetime : a Markov Model

    NORDMANN JP, LAFUMA A, DESCHASEAUX-VOINET C, BERDEAUX G

    J Glaucoma ; 14(6):463-469

  • Économie de la santĂ©

    Medical predictive Factors of Glaucoma Treatment Costs

    DENIS P, LAFUMA A, BERDEAUX G

    J Glaucoma ; 13(4):283-290

  • Économie de la santĂ©

    Cost and effectiveness of brinzolamide versus dorzolamide in current practice : an analysis based on the UK-GPRD database

    DESCHASEAUX-VOINET C, LAFUMA A, BERDEAUX G

    Journal of Medical Economics ; 6 :69-78

  • Économie de la santĂ©

    Cost-effectiveness of olopatadine in seasonal allergic conjunctivitis treatment

    LAFUMA A, SMITH AF

    Expert Rev Pharmacoecon Outcomes Res ; 2(6): 89-94

  • Économie de la santĂ©

    Cost effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries

    GOUVEIA PINTO C, LAFUMA A, FAGNANI F, NUIJTEN MJC, BERDEAUX G

    Pharmacoeconomics ; 19 (3): 255-265

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

    MARIOTTI C, DAHAN E, NICOLAI M, LEVITZ L, BOUEE S.

    Eye ; 2014;28(1):1-8

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Response to: RE: Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device.

    MARIOTTI C, DAHAN E, NICOLAI M, LEVITZ L, BOUEE S.

    Eye ; 2014;28(8):1034-1035

  • Pharmaco-EpidĂ©miologie

    Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension.

    BAUDOUIN C, RENARD JP, NORDMANN JP, DENIS P, LACHKAR Y, SELLEM E, ROULAND JF, JEANBAT V, BOUEE S.

    Eur J Ophtalmol ; 2013;23(1):47-54

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Transforming scales of measurement of visual acuity at the group level

    KHOSHNOOD B, MESBAH M, JEANBAT V, LAFUMA A, BERDEAUX G

    Ophthalmic Physiol Opt ; 2010;30(6):816-823

  • Pharmaco-EpidĂ©miologie

    Neodymium : YAG laser rates after bilateral implantation of hydrophobic or hydrophilic multifocal intraoculenses : twenty-four month retrospective comparative study

    GAUTHIER L, LAFUMA A, LAURENDEAU C, BERDEAUX G

    J Cataract Refract Surg ; 2010;36(7):1195-1200

  • Pharmaco-EpidĂ©miologie

    Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control : a survey

    NORDMANN JP, BAUDOUIN C, RENARD JP, DENIS P, LAFUMA A, LAURENDEAU C, JEANBAT V, BERDEAUX G

    Clin Ophtalmol ; 2010;4:731-739

  • Économie de la santĂ©

    Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands

    DE VRIES NE, LAURENDEAU C, LAFUMA A, BERDEAUX G, NUIJTS RM

    Eye ; 2010;24(4):663-672

  • Économie de la santĂ©

    Inpatient costs of endophthalmitis evaluated for the whole of France

    COLIN X, BERDEAUX G, LAFUMA A, SALVANET-BOUCHARA A, KODJIKIAN L

    Appl Health Econ Health Policy ; 2010;8(1):53-60

  • Économie de la santĂ©

    Efficacy of moxifloxacin in treating bacterial conjunctivitis : a meta-analysis

    KODJIKIAN L, LAFUMA A, KHOSHNOOD B, LAURENDEAU C, BERDEAUX G

    J Fr Ophtalmol ; 2010;33(4):227-233